Ramagopalan SV - Search Results

1

IGHV4-39 deletion polymorphism does not associate with risk or outcome of multiple sclerosis.

Watson CT, Ramagopalan SV, Morrison KM, Ebers GC, Breden F. Watson CT, et al. Among authors: ramagopalan sv. J Neuroimmunol. 2010 Aug 25;225(1-2):164-6. doi: 10.1016/j.jneuroim.2010.04.012. Epub 2010 May 15. J Neuroimmunol. 2010. PMID: 20471699

2

The genetics of clinical outcome in multiple sclerosis.

Ramagopalan SV, Deluca GC, Degenhardt A, Ebers GC. Ramagopalan SV, et al. J Neuroimmunol. 2008 Sep 15;201-202:183-99. doi: 10.1016/j.jneuroim.2008.02.016. Epub 2008 Jul 15. J Neuroimmunol. 2008. PMID: 18632165 Review.

3

Mutations in the hemochromatosis gene and the clinical outcome of multiple sclerosis.

Ramagopalan SV, Cukjati M, Cernilec M, DeLuca GC, Dyment DA, Degenhardt A, Sadovnick AD, Serbec VC, Ebers GC, Duquette P. Ramagopalan SV, et al. J Neuroimmunol. 2008 Oct 15;203(1):104-7. doi: 10.1016/j.jneuroim.2008.06.036. J Neuroimmunol. 2008. PMID: 18675463

4

Variants in ST8SIA1 do not play a major role in susceptibility to multiple sclerosis in Canadian families.

Ramagopalan SV, Morrison KM, Para A, Handel A, Disanto G, Handunnetthi L, Orton SM, Sadovnick AD, Ebers GC. Ramagopalan SV, et al. J Neuroimmunol. 2009 Jul 25;212(1-2):142-4. doi: 10.1016/j.jneuroim.2009.04.017. Epub 2009 May 9. J Neuroimmunol. 2009. PMID: 19428123

5

No evidence for an effect of DNA methylation on multiple sclerosis severity at HLA-DRB1*15 or HLA-DRB5.

Handel AE, De Luca GC, Morahan J, Handunnetthi L, Sadovnick AD, Ebers GC, Ramagopalan SV. Handel AE, et al. Among authors: ramagopalan sv. J Neuroimmunol. 2010 Jun;223(1-2):120-3. doi: 10.1016/j.jneuroim.2010.03.002. Epub 2010 Apr 14. J Neuroimmunol. 2010. PMID: 20394989

6

Estimating the proportion of variation in susceptibility to multiple sclerosis captured by common SNPs.

Watson CT, Disanto G, Breden F, Giovannoni G, Ramagopalan SV. Watson CT, et al. Among authors: ramagopalan sv. Sci Rep. 2012;2:770. doi: 10.1038/srep00770. Epub 2012 Oct 25. Sci Rep. 2012. PMID: 23105968 Free PMC article.

7

No effect of APOE and PVRL2 on the clinical outcome of multiple sclerosis.

Ramagopalan SV, Deluca GC, Morrison KM, Herrera BM, Dyment DA, Orton S, Bihoreau MT, Degenhardt A, Pugliatti M, Sadovnick AD, Sotgiu S, Ebers GC. Ramagopalan SV, et al. J Neuroimmunol. 2007 May;186(1-2):156-60. doi: 10.1016/j.jneuroim.2007.02.003. Epub 2007 Mar 21. J Neuroimmunol. 2007. PMID: 17376543

8

Revisiting the T-cell receptor alpha/delta locus and possible associations with multiple sclerosis.

Watson CT, Para AE, Lincoln MR, Ramagopalan SV, Orton SM, Morrison KM, Handunnetthi L, Handel AE, Chao MJ, Morahan J, Sadovnick AD, Breden F, Ebers GC. Watson CT, et al. Among authors: ramagopalan sv. Genes Immun. 2011 Mar;12(2):59-66. doi: 10.1038/gene.2010.65. Epub 2011 Jan 27. Genes Immun. 2011. PMID: 21270827 Review.

9

A genome-wide scan in forty large pedigrees with multiple sclerosis.

Willer CJ, Dyment DA, Cherny S, Ramagopalan SV, Herrera BM, Morrison KME, Sadovnick AD, Risch NJ, Ebers GC. Willer CJ, et al. Among authors: ramagopalan sv. J Hum Genet. 2007;52(12):955-962. doi: 10.1007/s10038-007-0194-6. Epub 2007 Nov 15. J Hum Genet. 2007. PMID: 18000641

10

Genes for multiple sclerosis.

Ramagopalan SV, Ebers GC. Ramagopalan SV, et al. Lancet. 2008 Jan 26;371(9609):283-5. doi: 10.1016/S0140-6736(08)60145-2. Lancet. 2008. PMID: 18294983 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

315 results

Search Page